CYTOO
Joanne Young has extensive experience in research and development, with a background in postdoctoral positions at various prestigious institutions such as EMBL, University of Heidelberg, and University of Victoria. Currently serving as the Director of R&D at CYTOO, Joanne has also held roles including Associate Director Project & Alliance Management and Senior Scientist. With a PhD from Paris-Sud University, Joanne's expertise lies in gene therapy, project management, and advanced light microscopy.
This person is not in any teams
CYTOO
CYTOO is a preclinical stage drug discovery company specialized in muscular and neuromuscular disorders. CYTOO partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies and develops its own drug candidates. CYOO has developed a fully mature human in vitro muscle model (MyoScreen) derived from primary human samples (healthy and pathological myoblasts) for generating NCEs from a variety of pathological conditions (rare, chronic). Core expertise lies on in vitro muscle regeneration, contraction, hypertrophy, and metabolism.